Back
Eaton Vance Enhanced Equity Income Fund II Vs. Neurogene Industry Stock Comparison
Buy
65
EOS
Eaton Vance Enhanced Equity Income Fund II
Last Price:
22.19
Seasonality Move:
1.73%
Buy
75
NGNE
Neurogene
Last Price:
65.96
Seasonality Move:
58.98%
Buy
65
Eaton Vance Enhanced Equity Income Fund II (EOS)
is a Buy
Is Eaton Vance Enhanced Equity Income Fund II a Buy, Sell or Hold?
- The current Eaton Vance Enhanced Equity Income Fund II [EOS] share price is $22.07. The Score for EOS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- EOS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Neurogene (NGNE)
is a Buy
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $66.00. The Score for NGNE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NGNE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EOS Stock Price Chart
What is Eaton Vance Enhanced Equity Income Fund II's stock price today?
-
The Eaton Vance Enhanced Equity Income Fund II share price today is $22.07
The current trend is moderately bearish and EOS is experiencing selling pressure, which indicates risk of future bearish movement.
NGNE Stock Price Chart
EOS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 50.56 | Buy |
| Chaikin Money Flow: | -72090 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.76 - 22.4) | Sell |
| Bollinger Bands (100): | (21 - 22.16) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.06 | Buy |
| Relative Strength Index (14 RSI): | 75.97 | Buy |
| Chaikin Money Flow: | 176225 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.28 - 53.36) | Buy |
| Bollinger Bands (100): | (34.64 - 46.72) | Buy |
EOS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.21 | Sell |
| 20-day SMA: | 22.22 | Sell |
| 50-day SMA: | 21.74 | Buy |
| 200-day SMA: | 20.86 | Buy |
| 8-day EMA: | 22.19 | Sell |
| 20-day EMA: | 22.12 | Sell |
| 50-day EMA: | 21.84 | Buy |
| 200-day EMA: | 20.78 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.43 | Buy |
| 20-day SMA: | 49.56 | Buy |
| 50-day SMA: | 43.32 | Buy |
| 200-day SMA: | 37.93 | Buy |
| 8-day EMA: | 50.65 | Buy |
| 20-day EMA: | 48.54 | Buy |
| 50-day EMA: | 44.96 | Buy |
| 200-day EMA: | 36.96 | Buy |
Eaton Vance Enhanced Equity Income Fund II Earnings Growth & EOS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
Eaton Vance Enhanced Equity Income Fund II Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||